Royalty Pharma (RPRX) News Today $26.22 +0.21 (+0.81%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Royalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading Volume - What's Next?Royalty Pharma (NASDAQ:RPRX) Sees Large Volume Increase - Still a Buy?November 19 at 2:00 PM | marketbeat.comStrong Buy Rating for Royalty Pharma: Robust Revenue Growth and Promising PipelineNovember 19 at 12:46 PM | markets.businessinsider.comRoyalty Pharma price target raised to $39 from $38 at BofANovember 19 at 12:46 PM | markets.businessinsider.comVictory Capital Management Inc. Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Victory Capital Management Inc. lifted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 26.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 849,035 shares of the biopharmaceutical company's sNovember 19 at 3:49 AM | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stake Reduced by Amalgamated BankAmalgamated Bank decreased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 70.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,469 shares of the biopharmaceutical cNovember 17, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sets New 52-Week Low - Time to Sell?Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year Low - Here's What HappenedNovember 15, 2024 | marketbeat.comSimplify Asset Management Inc. Increases Position in Royalty Pharma plc (NASDAQ:RPRX)Simplify Asset Management Inc. lifted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 67.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,066 shares of the biopharmaceutical company's stock afNovember 15, 2024 | marketbeat.comRoyalty Pharma Announces Inaugural Prize for Impact in HealthcareNovember 14, 2024 | globenewswire.comRoyalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying IssuesNovember 14, 2024 | finance.yahoo.com3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a DecadeNovember 14, 2024 | fool.comNew South Capital Management Inc. Has $69.77 Million Stake in Royalty Pharma plc (NASDAQ:RPRX)New South Capital Management Inc. increased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,466,371 shares of the biopharmaceutical company's stock aNovember 12, 2024 | marketbeat.comBaillie Gifford & Co. Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)Baillie Gifford & Co. trimmed its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 1.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,122,491 shares of the biopharmaceutical company's stock after sNovember 12, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Holdings Cut by Los Angeles Capital Management LLCLos Angeles Capital Management LLC lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 13.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 387,697 shares of the biopharmaceutical company's sNovember 12, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stock Position Lifted by Van ECK Associates CorpVan ECK Associates Corp boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 171.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 101,500 shares of the biopharmaceutical comNovember 11, 2024 | marketbeat.comSummit Global Investments Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX)Summit Global Investments acquired a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 25,991 shares of the biopharmaceuticalNovember 10, 2024 | marketbeat.comCiti Keeps Their Buy Rating on Royalty Pharma (RPRX)November 10, 2024 | markets.businessinsider.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Executive Wealth Management LLCExecutive Wealth Management LLC lessened its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 23.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,700 shares of the bNovember 9, 2024 | marketbeat.comRoyalty Pharma: Massive Opportunity AheadNovember 9, 2024 | seekingalpha.comRoyalty Pharma (NASDAQ:RPRX) Sees Large Volume Increase - Here's What HappenedRoyalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading Volume - Here's What HappenedNovember 8, 2024 | marketbeat.comRoyalty Pharma Reports Strong Q3 2024 ResultsNovember 8, 2024 | markets.businessinsider.comRoyalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 MillionNovember 7, 2024 | finance.yahoo.comGeron spikes after Q3 beat and $375M funding dealNovember 7, 2024 | msn.comRoyalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic AcquisitionsNovember 7, 2024 | finance.yahoo.comGeron announces $375M in synthetic royalty, debt financings with Royalty PharmaNovember 7, 2024 | markets.businessinsider.comRoyalty Pharma to acquire royalty interest in Geron’s RYTELO for $125MNovember 7, 2024 | markets.businessinsider.comRoyalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | msn.comRoyalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 MillionNovember 7, 2024 | globenewswire.comRobeco Institutional Asset Management B.V. Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Robeco Institutional Asset Management B.V. lifted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 48.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 504,835 shares of the biopharmaceuticalNovember 7, 2024 | marketbeat.comRoyalty Pharma plc (RPRX) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comRoyalty Pharma plc 2024 Q3 - Results - Earnings Call PresentationNovember 6, 2024 | seekingalpha.comRoyalty Pharma reports Q3 revenue $565M, consensus $696.1MNovember 6, 2024 | markets.businessinsider.comRoyalty Pharma Reports Third Quarter 2024 ResultsNovember 6, 2024 | globenewswire.comRiver Road Asset Management LLC Grows Position in Royalty Pharma plc (NASDAQ:RPRX)River Road Asset Management LLC increased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 9.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 469,980 shares of the biopharmaceutical comNovember 6, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Raised to "Buy" at StockNews.comStockNews.com upgraded shares of Royalty Pharma from a "hold" rating to a "buy" rating in a research note on Tuesday.November 5, 2024 | marketbeat.comRoyalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for NiktimvoNovember 4, 2024 | globenewswire.comKalVista Pharmaceuticals Shares Rise 11% on Royalty Financing Deal, Stock OfferingNovember 4, 2024 | marketwatch.comSyndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™November 4, 2024 | prnewswire.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by abrdn plcabrdn plc cut its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 91.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,352 shares of the biopharmaceutical company's stock after selling 1,083,657 sNovember 4, 2024 | marketbeat.comCannon Global Investment Management LLC Invests $976,000 in Royalty Pharma plc (NASDAQ:RPRX)Cannon Global Investment Management LLC bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 34,500 shares of the biopharmaceutical comNovember 3, 2024 | marketbeat.comChina Universal Asset Management Co. Ltd. Acquires 33,206 Shares of Royalty Pharma plc (NASDAQ:RPRX)China Universal Asset Management Co. Ltd. increased its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 62.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 86,190 shares of the biopharmaceutical coOctober 29, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and five have assigned a buOctober 29, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Price Target Cut to $40.00Citigroup decreased their price target on Royalty Pharma from $60.00 to $40.00 and set a "buy" rating for the company in a research note on Friday.October 25, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stock Position Raised by Raymond James & AssociatesRaymond James & Associates increased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 9.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 805,080 shares of the biopharmaceuticalOctober 25, 2024 | marketbeat.comKeene & Associates Inc. Makes New $539,000 Investment in Royalty Pharma plc (NASDAQ:RPRX)Keene & Associates Inc. purchased a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the third quarter, according to its most recent filing with the SEC. The firm purchased 19,050 shares of the biopharmaceutical company's stock, valued at approximately $539,000. Other larOctober 24, 2024 | marketbeat.com3 Dividend Growth Stocks to Buy Now for a Lifetime of Passive IncomeOctober 20, 2024 | fool.comMarathon Asset Management Ltd Acquires 18,424 Shares of Royalty Pharma plc (NASDAQ:RPRX)Marathon Asset Management Ltd raised its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 2.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 762,151 sharesOctober 18, 2024 | marketbeat.comInlet Private Wealth LLC Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX)Inlet Private Wealth LLC purchased a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 188,460 shares of the biopharmaceutical companyOctober 17, 2024 | marketbeat.comRoyalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024October 16, 2024 | globenewswire.comSwedbank AB Has $311.96 Million Position in Royalty Pharma plc (NASDAQ:RPRX)Swedbank AB raised its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 2.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,027,370 shares of the biopharmaceutical coOctober 15, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Declares $0.21 Quarterly DividendRoyalty Pharma plc (NASDAQ:RPRX) announced a quarterly dividend on Friday, October 11th. Stockholders of record on Friday, November 15th will be paid a dividend of 0.21 per share by the biopharmaceutical company on Tuesday, December 10th. This represents a $0.84 annualized dividend and a dividend yield of 3.00%. The ex-dividend date is Friday, November 15th.October 12, 2024 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼0.830.76▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼106▲RPRX Articles Average Week Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Regeneron Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPRX Stock Alerts